Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
2001 1
2002 2
2003 1
2004 6
2005 1
2006 4
2007 3
2008 5
2009 3
2010 5
2011 3
2012 1
2013 2
2014 5
2015 3
2016 7
2017 7
2018 3
2019 3
2020 4
2021 2
2022 8
2023 5
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Place des mesures rapportées par les patients (PROMS/PREMS) dans l’évaluation et la valorisation des technologies de santé en France.
Roussel C, Chassany O, Durand-Zaleski I, Josseran A, Alter L, Auquier P, Bourguignon S, Cachoux J, Desforges C, Fernandez J, Gaudin AF, Germe AF, Haenel E, Olivier P, Maillard N, Naïditch N, Nguyen T, Péan C, Rumeau-Pichon C, Sales JP, Schmidely N, Tuppin P, Vray M. Roussel C, et al. Among authors: gaudin af. Therapie. 2022 Jan-Feb;77(1):89-102. doi: 10.1016/j.therap.2022.01.007. Epub 2022 Jan 13. Therapie. 2022. PMID: 35115142 French. No abstract available.
Demandes d’études post-inscription (EPI), suivi des patients en vie réelle : évolution de la place des bases de données.
Berdaï D, Thomas-Delecourt F, Szwarcensztein K; table ronde « recherche clinique et méthodologie » des Ateliers de Giens XXXIII; d'Andon A, Collignon C, Comet D, Déal C, Dervaux B, Gaudin AF, Lamarque-Garnier V, Lechat P, Marque S, Maugendre P, Méchin H, Moore N, Nachbaur G, Robain M, Roussel C, Tanti A, Thiessard F. Berdaï D, et al. Among authors: gaudin af. Therapie. 2018 Feb;73(1):1-12. doi: 10.1016/j.therap.2017.12.001. Epub 2017 Dec 12. Therapie. 2018. PMID: 29499906 French. No abstract available.
Characteristics, management, and healthcare resources of patients with advanced non-small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national database analysis.
Assié JB, Grumberg V, Reynaud D, Gaudin AF, Batisse A, Jolivel R, Jouaneton B, Cotté FE, Chouaïd C. Assié JB, et al. Among authors: gaudin af. Respir Med Res. 2023 Nov;84:101051. doi: 10.1016/j.resmer.2023.101051. Epub 2023 Oct 6. Respir Med Res. 2023. PMID: 37897879 Free article.
Organizational Impact of Immunotherapies in Advanced Cancers in France.
Grumberg V, Chouaïd C, Gaudin AF, Le Tourneau C, Marabelle A, Bongiovanni-Delarozière I, Cotté FE, Borget I. Grumberg V, et al. Among authors: gaudin af. JCO Glob Oncol. 2023 Aug;9:e2300026. doi: 10.1200/GO.23.00026. JCO Glob Oncol. 2023. PMID: 37595168 Free PMC article. Review.
Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study.
Roupret M, Brouquet A, Colrat F, Diez-Andreu P, Prudent A, Chartier M, Gaudin AF, Bugnard F, Chillotti L, Bénard S, Branchoux S, Bellera C, Negrier S. Roupret M, et al. Among authors: gaudin af. World J Urol. 2023 Apr;41(4):1069-1075. doi: 10.1007/s00345-023-04335-w. Epub 2023 Mar 16. World J Urol. 2023. PMID: 36929410 Free PMC article.
74 results